Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fungal Endocarditis.

Eyal Nadir1, Ethan Rubinstein

  • 1Infectious Diseases Unit, Sheba Medical Center, Tel Hashomer, 52621, Tel-Aviv University, School of Medicine, Israel. ethan.rubinstein@sheba.health.gov.il

Current Infectious Disease Reports
|July 22, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel.

The New England journal of medicine·2021
Same author

Effect of a national policy of universal masking and uniform criteria for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) exposure on hospital staff infection and quarantine.

Infection control and hospital epidemiology·2021
Same author

High incidence of dengue in Israel travelers to Kathmandu, Nepal, in 2019.

Journal of travel medicine·2020
Same author

Plasmodium malariae in Israeli Travelers: A Nationwide Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2017
Same author

Alternative pre-approved and novel therapies for the treatment of anthrax.

BMC infectious diseases·2016
Same author

In vitro evaluation of the effect of linezolid and levofloxacin on Bacillus anthracis toxin production, spore formation and cell growth.

The Journal of antimicrobial chemotherapy·2016
Same journal

Chagas Disease: An Opportunistic Infection in AIDS.

Current infectious disease reports·2026
Same journal

Area-based Deprivation Indices and Healthcare-Associated Infections: A Narrative Review of Evidence.

Current infectious disease reports·2025
Same journal

Next Steps: Studying Diabetic Foot Infections with Next-Generation Molecular Assays.

Current infectious disease reports·2024
Same journal

To Tweet or Not to Tweet-a Review of the Viral Power of Twitter for Infectious Diseases.

Current infectious disease reports·2024
Same journal

Web alert.

Current infectious disease reports·2024
Same journal

Bacterial Vaginosis in Postmenopausal Women.

Current infectious disease reports·2023
See all related articles

Fungal endocarditis (FE) is increasingly common, often linked to valvular heart disease. Early diagnosis via echocardiography and new treatments are improving patient outcomes for this serious infection.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Mycology

Background:

  • Fungal endocarditis (FE) is an emerging clinical concern, with Candida and Aspergillus species being the most frequent causative agents.
  • Valvular heart disease is a prerequisite for FE. Predisposing factors include intravenous devices and antibiotic use for yeast FE, and immunosuppression for mold FE.

Purpose of the Study:

  • To review the current understanding of fungal endocarditis, focusing on diagnosis and treatment advancements.
  • To highlight the role of echocardiography in early FE detection and its impact on prognosis.

Main Methods:

  • Review of recent medical literature on fungal endocarditis.
  • Analysis of diagnostic techniques, particularly echocardiography.
  • Discussion of current and future therapeutic strategies.

Related Experiment Videos

Main Results:

  • Echocardiography has become a crucial tool for the early diagnosis of FE, contributing to improved patient prognoses.
  • Advances in antifungal therapies and diagnostic methods are anticipated to further enhance treatment efficacy and outcomes.

Conclusions:

  • Prompt diagnosis and effective treatment are critical for improving the prognosis of fungal endocarditis.
  • Future directions include the development of non-culture-based diagnostic tests and novel antifungal agents to combat FE.